Sickle Cell Medical Advocacy, Inc. – Trademark Portfolio

Entity Type: 03

Sickle Cell Medical Advocacy, Inc. holds 1 U.S. trademark filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 35 (Advertising & Business) — 1 filings in this category. Currently, 1 trademark is registered. Notable registered marks include SCMA SICKLE CELL MEDICAL ADVOCACY INC. EDUCATION AND TRAINING FOR PATIENTS AND CAREGIVERS. The owner is based in Orlando, FL.

1317 Edgewater Drive, Suite 5035

Orlando, FL 32084

1 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

Trademark Classifications

Sickle Cell Medical Advocacy, Inc.'s trademark portfolio spans 1 Nice Classification class, reflecting the scope of goods and services protected under their brand portfolio.

35
Advertising & Business (1 filing)

Advertising; business management; business administration; office functions

Frequently Asked Questions

How many trademarks does Sickle Cell Medical Advocacy, Inc. have?

Sickle Cell Medical Advocacy, Inc. has 1 U.S. trademark filed with the USPTO. Of these, 1 registered.

What trademark classes does Sickle Cell Medical Advocacy, Inc. file in?

Sickle Cell Medical Advocacy, Inc. files trademarks across 1 Nice Classification class. The most active classes are Class 35 (Advertising & Business). Class 35 covers advertising; business management; business administration; office functions.

What are Sickle Cell Medical Advocacy, Inc.'s most well-known trademarks?

Sickle Cell Medical Advocacy, Inc.'s registered trademark portfolio includes well-known marks such as SCMA SICKLE CELL MEDICAL ADVOCACY INC. EDUCATION AND TRAINING FOR PATIENTS AND CAREGIVERS. These are among 1 currently registered trademark in the portfolio.

What is Sickle Cell Medical Advocacy, Inc.'s trademark registration success rate?

Sickle Cell Medical Advocacy, Inc. has a 100% trademark registration rate, with 1 out of 1 resolved applications resulting in successful registration. Currently, 0 applications are pending review.